表紙
市場調査レポート

CEA検査市場:米国・欧州・日本の検査件数、売上高予測、サプライヤーシェア(国別)

Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

発行 Venture Planning Group 商品コード 166153
出版日 ページ情報 英文 250 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
CEA検査市場:米国・欧州・日本の検査件数、売上高予測、サプライヤーシェア(国別) Carcinoembryonic Antigen (CEA): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
出版日: ページ情報: 英文 250 Pages
概要

当レポートでは、米国・欧州(主要5ヶ国)・日本におけるCEA(癌胎児性抗原)検査市場について調査分析し、検査件数と売上高予測(国別・市場セグメント別)、主要サプライヤーの市場シェアを提供するほか、技術の概要、市場普及戦略、市場参入戦略などを概説し、主要企業プロファイルも含めて、概略以下の構成でお届けいたします。

イントロダクション

世界市場と技術の概要

  • CEA(癌胎児性抗原):臨床的意義と実施基準
  • 装置レビューと市場ニーズ
  • 現在/新興の技術
    • モノクローナル抗体とポリクローナル抗体
    • 免疫学的検定
    • 分子診断
    • バイオチップ/マイクロアレイ
    • 染色体分析
    • マイクロコンピューターとオートメーション
    • 人工知能
    • フローサイトメトリー
    • バイオセンサー
  • 代替/補完技術
    • CT(コンピュータ断層撮影)
    • MRI(磁気共鳴画像法)
    • NMR(核磁気共鳴法)
    • PET(ポジトロン断層法)
    • フォトニクス分光
  • 個別検査

フランス市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

ドイツ市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

イタリア市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

日本市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

スペイン市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

英国市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

米国市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新興のサプライヤー
    • 主な流通業者のタイプ
    • 市場セグメント

潜在的な市場参入障壁とリスク

  • 市場の成熟
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

競合企業プロファイル

  • Abbott
  • AdnaGen
  • Ambrilia Biopharma
  • AMDL
  • Beckman Coulter
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CanAG Diagnostics
  • CeMines
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • J&J Diagnostics
  • Kreatech
  • 共和メデックス
  • Mackay Life Sciences
  • Matritech
  • Myriad Genetics
  • OncoLab
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Veridex
  • 和光純薬
  • Wallac
  • Zila

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCA18877

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 250 pages and 15 tables

Table of Contents

I. Introduction

II. CEA Worldwide Market and Technology Overview

A. Carcinoembrionic Antigen (CEA): Clinical Significance and Laboratory Practices

B. Instrumentation Review And Market Needs

  • 1. Abbott AxSYM
  • 2. Abbott Architect c4000
  • 3. Abbott Architect i2000 Series
  • 4. Abbott Architect ci8200 System
  • 5. Beckman Coulter UniCel Series
  • 6. Beckman Coulter Access
  • 7. Binding Site ESP600
  • 8. bioMerieux Mini Vidas
  • 9. Carolina Chemistries BioLis 24i
  • 10. DiaSorin Liaison
  • 11. Horiba ABX Pentra 400
  • 12. Inverness DS2
  • 13. J&J Vitros ECi/ECiQ
  • 14. J&J Vitros 3600
  • 15. J&J Vitros 5600
  • 16. Olympus AU5400
  • 17. Olympus AU3000i
  • 18. Olympus AU2700
  • 19. Roche Modular Analytics
  • 20. Roche Cobas Integra 400
  • 21. Roche Cobas Integra 400 Plus
  • 22. Roche Elecsys
  • 23. Roche Cobas c311
  • 24. Siemens ADVIA Centaur
  • 25. Siemens Dimension
  • 26. Siemens Dimension RxL Max
  • 27. Siemens Dimension Vista 500
  • 28. Siemens Immulite
  • 29. Siemens Stratus
  • 30. Tosoh AIA-Series
  • 31. Vital Diagnostics ATAC 8000
  • 32. Vital Diagnostics Envoy 500

C. Current and Emerging Technologies

  • 1. Monoclonal and Polyclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Radioimmunoassay (RIA)
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Immunofiltration
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • d. Fluorescent Immunoassays
    • e. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • f. Latex Agglutination
    • g. Immunoprecipitation
    • H. Affinity Chromatographu
    • e. Liposome Flow-Injection Immunoassay
  • 3. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • PCR
      • DAP-PCR
      • Immuno-PCR
      • QC-PCR
      • CAR
      • DNA
      • HPA
      • LCR
      • NASBA
      • QBR
      • SDA
      • 3 SR, and others
  • 4. Chromosome Analysis
    • a. Chronic Myelogenous Leukemia (CML)
    • b. Acute Myeloid Leukemia (AML)
    • c. Acute Lymphoblastic Leukemia (ALL)
    • d. Malignant Lymphomas
    • Lymphoid Malignancies
    • e. Chronic Lymphocytic Leukemia (CLL)
    • f. Solid Cancers
    • g. Chromosomal Translocation and Oncogenes
  • 5. Artificial Intelligence
  • 6. Flow Cytometry
  • 7. Two Dimensional Gel Electrophoresis (2-DGE)
  • 8. Biosensors
  • 9. Competing/Complementing Technologies
  • a. CT
    • b. MRI
    • c. NMR
    • d. PET
    • e. Photonics Spectroscopy

E. Personal Testing

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. U.K.: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. U.S.A.: Market Size, Growth and Major Suppliers' Sales and Market Shares

X. Design Criteria for Decentralized Testing Products

XI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

XII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XIII. Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

List of Tables

  • Major Companies Developing or Marketing CEA Tests
  • France CEA Test Volume and Diagnostics Sales by Market Segment
  • France CEA Testing Market by Major Supplier
  • Germany CEA Test Volume and Diagnostics Sales by Market Segment
  • Germany CEA Testing Market by Major Supplier
  • Italy CEA Test Volume and Diagnostics Sales by Market Segment
  • Italy CEA Testing Market by Major Supplier
  • Japan CEA Test Volume and Diagnostics Sales by Market Segment
  • Japan CEA Testing Market by Major Supplier
  • Spain CEA Test Volume and Diagnostics Sales by Market Segment
  • Spain CEA Testing Market by Major Supplier
  • U.K. CEA Test Volume and Diagnostics Sales by Market Segment
  • U.K. CEA Testing Market by Major Supplier
  • U.S.A. CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S.A. CEA Testing Market by Major Supplier
Back to Top